Owlstone Medical

To add a bio or update company history, please click update information.

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

6 Oct 2025

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

Owlstone Medical develops breath-based diagnostic technologies that detect disease using chemical markers, enabling non-invasive screening and monitoring for cancer and chronic conditions at home or point of care.

Owlstone Medical

Life Sciences
Cambridge, United Kingdom
£36m
owlstonemedical.com
Update Information

More venture news

TRIMTECH Therapeutics
23 Jun 2026
TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
ExtensionLife Sciences
Houdini Bio
19 Jun 2026
Houdini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform
Pre-seedLife Sciences
Apoha
3 Jun 2026
Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
EquityLife Sciences

Owlstone Medical

News from Owlstone Medical

Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

More venture news

TRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases

Houdini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform

Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions